Smoking strongly increased the long-term risk of incident late, but not early, AMD, with a possibly greater effect in persons with a low HDL cholesterol level, a high ratio of total to HDL cholesterol, and low fish consumption.
Research Objective
To assess the association between smoking and long-term incident age-related macular degeneration (AMD).
Study Design
A population-based cohort study.
Location
Australia.
Funding Source
The Australian National Health and Medical Research Council.
Smoking strongly increased the long-term risk of incident late, but not early, AMD, with a possibly greater effect in persons with a low HDL cholesterol level, a high ratio of total to HDL cholesterol, and low fish consumption.
Relevant Methodology
Of 3654 Australians 49 years and older examined at baseline, 2454 were examined 5 years later, 10 years later, or both. Retinal photographs were taken to assess AMD. Smoking status was recorded at each interview.
Outcome Measures
AMD lesions.
Results
After controlling for age, sex, and other factors, current smokers had a 4-fold higher risk of late AMD than never smokers [relative risk (RR): 3.9; 95% confidence interval: 1.7-8.8]. Past smokers had a 3-fold higher risk of geographic atrophy (RR: 3.4; 95% confidence interval: 1.2-9.7). Joint exposure to current smoking and (1) the lowest level of high-density lipoprotein (HDL) cholesterol, (2) the highest total to HDL cholesterol ratio, or (3) low fish consumption was associated with a higher risk of late AMD than the effect of any risk factor alone. However, interactions between smoking and HDL cholesterol level, ratio of total to HDL cholesterol, and fish consumption were not statistically significant.
Conclusions
Smoking strongly increased the longterm risk of incident late, but not early, AMD, with a possibly greater effect in persons with a low HDL cholesterol level, a high ratio of total to HDL cholesterol, and low fish consumption.
Comment
Emily Y. Chew, MD National Eye Institute/ National Institutes of Health Bethesda, MD The Blue Mountains Eye Study (BES), a well-conducted population-based study from Australia, provided further evidence to support the association of increased advanced age-related macular degeneration (AMD) with cigarette smoking. This is the most consistent risk factor found in most studies that have adequate number of affected individuals with advanced AMD. In this current report, the cases of advanced AMD were newly diagnosed or ''incident'' cases found 10 years after the initial examination.
The analyses also found that the joint effects of smoking with other risk factors further increased the RR of advanced AMD, greater than the RR of each individual risk factor alone. These risk factors included decreased serum levels of HDL cholesterol and low fish consumption. However, the interaction terms in the analyses were not statistically significant. The number of advanced AMD were, unfortunately, not sufficient to evaluate in a multivariable regression model.
Despite the lack of power to conduct these fully adjusted analyses with the multivariable regression, these findings are of great interest to vision researchers as they provide support regarding potential etiologic pathways and treatments for AMD. The inverse association of fish consumption with advanced AMD has been reported in other studies. [1] [2] [3] Although not all studies showed a statistically significant association with AMD, high fish consumption was found to be protective in these observational studies. One of the key factors in fish may be the omega-3 long-chain polyunsaturated fatty acids (LCPUFAs) that are found in high levels in the retina. These LCPUFAs are known to have anti-inflammatory, antiangiogenic, and antioxidative properties. These observational data are sufficiently compelling that they are currently tested in a controlled, clinical trial for the potential to reduce the risk of advanced AMD (http://www.areds2.org).
Further interest into cardiovascular risk factors has been provided by the finding of low HDL cholesterol increasing the risk of advanced AMD. This factor has been inconsistent in the literature and may need further studies to confirm this finding.
Certainly, there are suggestions that AMD may share common risk factors with cardiovascular disease. Again, this would be important because potential preventive treatment may be instigated if indeed, the toxic effects of atherosclerosis may be prevented by increasing the function of the HDL cholesterol in such patients.
Currently, we have limited preventive therapy for AMD. The Age-Related Eye Disease Study supplements with antioxidative vitamins and minerals may reduce the risk of advanced AMD by 25% in those with moderate to high risk such as AMD. Other measures may include cessation of cigarette smoking and increasing dietary intake fish and foods rich in carotenoids, specifically, lutein/ zeaxanthin. Results from randomizedcontrolled clinical trials such as AREDS2 will provide further information regarding oral supplementation of omega-3 LCPUFAs or lutein/zeaxanthin.
